GROSSI, ILARIA
GROSSI, ILARIA
Dipartimento di Medicina Sperimentale
Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento.
2025-01-01 Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir.
2024-01-01 Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V
Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide
2025-01-01 Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L
Cryptic HBV activity is frequently observed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active art and can jeopardize the full control of HIV replication.
2024-01-01 Piermatteo, L; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino., V
Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level
2025-01-01 Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential.
2025-01-01 D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA
2025-01-01 D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir
2024-01-01 D'Anna, 1s; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide
2025-01-01 D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Torre, G; Tramontozzi, C; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
Kinetics of occult hepatitis B infection in people with HIV switching from HBV-active ART to long-acting cabotegravir/rilpivirine
2025-01-01 D’Anna, S; Magnapera, A; Grossi, I; Capra, N; Lolatto, R; Piermatteo, L; Bagaglio, S; Muccini, C; Salpini, R; Castagna, A; Svicher, V; Morsica, G
Malagnino Valutazione della risposta biochimica e virologica dopo 72 settimane di terapia con Bulevirtide ed analisi della cinetica virale intraepatica in una coorte di pazienti affetti da epatite delta.
2025-01-01 Di Lorenzo, A; D’Anna, S; Kontogiannis, D; Teti, E; Piermatteo, L; Grossi, I; Benedetti, L; Sabuzi, F; Iannetta, M; Geretti, Am; Svicher, V; Salpini, R; Sarmati, L; Malagnino, V
Persistent HBV cryptic activity is frequently revealed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active ART and can jeopardize the full control of HIV replication.
2024-01-01 Piermatteo, 1l; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino Oral presentation at -, V
The burden of HDV chronic infection and the gaps in HDV screening across Europe: an urgent need to strengthen diagnostic strategies at pan-European level
2025-01-01 Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Seguin-Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | Caratterizzazione intraepatica dell'attività di HDV sostenuta dall'integrazione di HBV al baseline e sotto trattamento. | Grossi, I; D'Anna, S; Di Lorenzo, A; Piermatteo, L; Ceccherini Silberstein, F; Sarmati, L; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. | Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-gen-2025 | Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide | Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L | Intervento a convegno | |
| 1-gen-2024 | Cryptic HBV activity is frequently observed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active art and can jeopardize the full control of HIV replication. | Piermatteo, L; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino., V | Intervento a convegno | |
| 1-gen-2025 | Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level | Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. | D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA | D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir | D'Anna, 1s; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide | D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Torre, G; Tramontozzi, C; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | Kinetics of occult hepatitis B infection in people with HIV switching from HBV-active ART to long-acting cabotegravir/rilpivirine | D’Anna, S; Magnapera, A; Grossi, I; Capra, N; Lolatto, R; Piermatteo, L; Bagaglio, S; Muccini, C; Salpini, R; Castagna, A; Svicher, V; Morsica, G | Intervento a convegno | |
| 1-gen-2025 | Malagnino Valutazione della risposta biochimica e virologica dopo 72 settimane di terapia con Bulevirtide ed analisi della cinetica virale intraepatica in una coorte di pazienti affetti da epatite delta. | Di Lorenzo, A; D’Anna, S; Kontogiannis, D; Teti, E; Piermatteo, L; Grossi, I; Benedetti, L; Sabuzi, F; Iannetta, M; Geretti, Am; Svicher, V; Salpini, R; Sarmati, L; Malagnino, V | Intervento a convegno | |
| 1-gen-2024 | Persistent HBV cryptic activity is frequently revealed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active ART and can jeopardize the full control of HIV replication. | Piermatteo, 1l; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino Oral presentation at -, V | Intervento a convegno | |
| 1-gen-2025 | The burden of HDV chronic infection and the gaps in HDV screening across Europe: an urgent need to strengthen diagnostic strategies at pan-European level | Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Seguin-Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V | Intervento a convegno |